These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
182 related items for PubMed ID: 25255433
1. Design, synthesis, in silico molecular docking and biological evaluation of novel oxadiazole based thiazolidine-2,4-diones bis-heterocycles as PPAR-γ agonists. Nazreen S, Alam MS, Hamid H, Yar MS, Shafi S, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Ali Y, Kharbanda C, Pillai KK. Eur J Med Chem; 2014 Nov 24; 87():175-85. PubMed ID: 25255433 [Abstract] [Full Text] [Related]
2. Design, Synthesis, and Biological Evaluation of Thiazolidine-2,4-dione Conjugates as PPAR-γ Agonists. Nazreen S, Alam MS, Hamid H, Shahar Yar M, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai K. Arch Pharm (Weinheim); 2015 Jun 24; 348(6):421-32. PubMed ID: 25900064 [Abstract] [Full Text] [Related]
3. Thiazolidine-2,4-diones derivatives as PPAR-γ agonists: synthesis, molecular docking, in vitro and in vivo antidiabetic activity with hepatotoxicity risk evaluation and effect on PPAR-γ gene expression. Nazreen S, Alam MS, Hamid H, Yar MS, Dhulap A, Alam P, Pasha MA, Bano S, Alam MM, Haider S, Kharbanda C, Ali Y, Pillai KK. Bioorg Med Chem Lett; 2014 Jul 15; 24(14):3034-42. PubMed ID: 24890090 [Abstract] [Full Text] [Related]
4. Synthesis, docking, in vitro and in vivo antidiabetic activity of pyrazole-based 2,4-thiazolidinedione derivatives as PPAR-γ modulators. Naim MJ, Alam O, Alam MJ, Shaquiquzzaman M, Alam MM, Naidu VGM. Arch Pharm (Weinheim); 2018 Apr 15; 351(3-4):e1700223. PubMed ID: 29400412 [Abstract] [Full Text] [Related]
6. Design, synthesis and biological evaluation of novel 5-(imidazolyl-methyl) thiazolidinediones as antidiabetic agents. Shakour N, Sahebkar A, Karimi G, Paseban M, Tasbandi A, Mosaffa F, Tayarani-Najaran Z, Ghodsi R, Hadizadeh F. Bioorg Chem; 2021 Oct 15; 115():105162. PubMed ID: 34314919 [Abstract] [Full Text] [Related]
7. Synthesis and evaluation of new 1,2,4-oxadiazole based trans- acrylic acid derivatives as potential PPAR-alpha/gamma dual agonist. Kaur P, Bhat ZR, Bhat S, Kumar R, Kumar R, Tikoo K, Gupta J, Khurana N, Kaur J, Khatik GL. Bioorg Chem; 2020 Jul 15; 100():103867. PubMed ID: 32353564 [Abstract] [Full Text] [Related]
8. Discovery of thiazolidine-2,4-dione/biphenylcarbonitrile hybrid as dual PPAR α/γ modulator with antidiabetic effect: in vitro, in silico and in vivo approaches. Hidalgo-Figueroa S, Ramírez-Espinosa JJ, Estrada-Soto S, Almanza-Pérez JC, Román-Ramos R, Alarcón-Aguilar FJ, Hernández-Rosado JV, Moreno-Díaz H, Díaz-Coutiño D, Navarrete-Vázquez G. Chem Biol Drug Des; 2013 Apr 15; 81(4):474-83. PubMed ID: 23289972 [Abstract] [Full Text] [Related]
9. Rational design and synthesis of some PPAR-γ agonists: Substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. Chhajed SS, Chaskar S, Kshirsagar SK, Haldar GM, Kar Mahapatra D. Comput Biol Chem; 2017 Apr 15; 67():260-265. PubMed ID: 28193552 [Abstract] [Full Text] [Related]
12. Synthesis, characterization, biological evaluation and docking of coumarin coupled thiazolidinedione derivatives and its bioisosteres as PPARγ agonists. Shukla S, Kumar P, Das N, Moorthy NS, Shrivastava SK, Trivedi P, Srivastava RS. Med Chem; 2012 Sep 15; 8(5):834-45. PubMed ID: 22741802 [Abstract] [Full Text] [Related]
13. Synthesis, molecular docking and anti-diabetic evaluation of 2,4-thiazolidinedione based amide derivatives. Naim MJ, Alam MJ, Nawaz F, Naidu VGM, Aaghaz S, Sahu M, Siddiqui N, Alam O. Bioorg Chem; 2017 Aug 15; 73():24-36. PubMed ID: 28582649 [Abstract] [Full Text] [Related]
14. Novel hybrids of benzothiazole-1,3,4-oxadiazole-4-thiazolidinone: Synthesis, in silico ADME study, molecular docking and in vivo anti-diabetic assessment. Bhutani R, Pathak DP, Kapoor G, Husain A, Iqbal MA. Bioorg Chem; 2019 Mar 15; 83():6-19. PubMed ID: 30339863 [Abstract] [Full Text] [Related]